NK

NantKwest
NASDAQ

实时行情|Nasdaq Last Sale

1.340
+0.040
+3.08%
已收盘, 16:00 09/17 EDT
开盘
1.300
昨收
1.300
最高
1.370
最低
1.300
成交量
7.59万
成交额
--
52周最高
4.230
52周最低
0.9300
市值
1.32亿
市盈率(TTM)
-1.4779
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

落后大盘

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NK 新闻

  • 日本社交巨头Line推出加密交易平台Bitmax
  • TechWeb.44分钟前
  • WeWork拟今年完成IPO:估值缩水八成,创始人表悔意
  • 澎湃新闻.50分钟前
  • 财经天下:IMF新掌门将面临哪些挑战?
  • 中国新闻网.54分钟前
  • 13家大型投行前瞻:美联储料降息25个基点 微调声明
  • 汇通网.59分钟前

更多

所属板块

生物技术和医学研究
+0.26%
制药与医学研究
+0.57%

热门股票

名称
价格
涨跌幅

NK 简况

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or infected cell by direct killing by binding to stress ligands expressed by the diseased cell with the release of toxic granules directly into the tumor cell; antibody mediated killing by binding to antibodies administered in combination and enhancing the cancer killing effect of the administered antibody, enabling targeted cell killing through antibody dependent cellular cytotoxicity (ADCC), and target activated killing by binding to known or newly discovered tumor-specific antigens expressed on the surface of tumor cells and inducing cell death by the release of toxic granules directly into the tumor cell and by the release of cytokines and chemokines.
展开

Webull提供Nantkwest Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。